Adresse

Gustave Roussy
114, rue Édouard-Vaillant
94805 Villejuif Cedex - France

Standard

Tel : +33 (0)1 42 11 42 11

Urgences

Avant toute venue aux urgences, il est impératif de téléphoner au (0)1 42 11 42 11. En cas de venue sans appel préalable, vous serez transféré dans un autre hôpital.

GUSTAVE ROUSSY
1er centre de lutte contre le cancer en Europe, 4 000 professionnels mobilisés

Pathologie Expérimentale et TRAnslationnelle (PETRA)

Responsable :
Pr Cécile BADOUAL

 

Envoyer un e-mail
Frise de présentation (bandeau): 
Pathologie Expérimentale et TRAnslationnelle (PETRA)

Plateforme PETRA : Publications

  • TREM2-Expressing Multinucleated Giant Macrophages Are a Biomarker of Good Prognosis in Head and Neck Squamous Cell Carcinoma
    (RT036.22) IF : 29,7
    Gessain G, Anzali AA, Lerousseau M, Mulder K, Bied M, Auperin A, Stockholm D, Signolle N, Sassi F, Marques Da Costa ME, Marchais A, Sayadi A, Weidner D, Uderhardt S, Blampey Q, Nakkireddy SR, Broutin S, Dutertre CA, Busson P, Walter T, Marhic A, Moya-Plana A, Guerlain J, Breuskin I, Casiraghi O, Gorphe P, Classe M, Scoazec JY, Blériot C, Ginhoux F.
    Cancer Discov. 2024 Dec 2;14(12):2352-2366. doi: 10.1158/2159-8290.CD-24-0018. PMID: 3927032
  • The CD47/TSP-1 axis: a promising avenue for ovarian cancer treatment and biomarker research.
    (RT128.14) IF : 27,7
    Moniot A, Schneider C, Chardin L, Yaniz-Galende E, Genestie C, Etiennot M, Henry A, Drelon C, Le Formal A, Langlois B, Venat L, Louvet C, Favier L, Lortholary A, Berton-Rigaud D, Dohollou N, Desauw C, Fabbro M, Malaurie E, Dubot C, Kurtz JE, Bonichon Lamichhane N, Pujade-Lauraine É, Jeanne A, Leary A, Dedieu S.
    Mol Cancer. 2024 Aug 14;23(1):166. doi: 10.1186/s12943-024-02073-0. PMID: 39138571
  • Organoids for Functional Precision Medicine in Advanced Pancreatic Cancer.
    (PE + RC STING) IF : 25,7
    Boilève A, Cartry J, Goudarzi N, Bedja S, Mathieu JRR, Bani MA, Nicolle R, Mouawia A, Bouyakoub R, Nicotra C, Ngo-Camus M, Job B, Lipson K, Boige V, Valéry M, Tarabay A, Dartigues P, Tselikas L, de Baere T, Italiano A, Cosconea S, Gelli M, Fernandez-de-Sevilla E, Annereau M, Malka D, Smolenschi C, Ducreux M, Hollebecque A, Jaulin F.
    Gastroenterology. 2024 Oct;167(5):961-976.e13. doi: 10.1053/j.gastro.2024.05.032. Epub 2024 Jun 10. PMID: 38866343
    Remerciements adressés à Olivia Bawa
  • Organoids for Functional Precision Medicine in Advanced Pancreatic Cancer.
    (PE) IF : 25,7
    Boilève A, Cartry J, Goudarzi N, Bedja S, Mathieu JRR, Bani MA, Nicolle R, Mouawia A, Bouyakoub R, Nicotra C, Ngo-Camus M, Job B, Lipson K, Boige V, Valéry M, Tarabay A, Dartigues P, Tselikas L, de Baere T, Italiano A, Cosconea S, Gelli M, Fernandez-de-Sevilla E, Annereau M, Malka D, Smolenschi C, Ducreux M, Hollebecque A, Jaulin F.
    Gastroenterology. 2024 Oct;167(5):961-976.e13. doi: 10.1053/j.gastro.2024.05.032. Epub 2024 Jun 10. PMID: 38866343
  • Single-cell multiomics profiling reveals heterogeneous transcriptional programs and microenvironment in DSRCTs
    (RT026.20) IF : 11.7
    Henon C, Vibert J, Eychenne T, Gruel N, Colmet-Daage L, Ngo C, Garrido M, Dorvault N, Marques Da Costa ME, Marty V, Signolle N, Marchais A, Herbel N, Kawai-Kawachi A, Lenormand M, Astier C, Chabanon R, Verret B, Bahleda R, Le Cesne A, Mechta-Grigoriou F, Faron M, Honoré C, Delattre O, Waterfall JJ, Watson S, Postel-Vinay S.Cell Rep Med. 2024 Jun 18;5(6):101582. doi: 10.1016/j.xcrm.2024.101582. Epub 2024 May 22.PMID: 38781959
  • Immune predictors of response to immune checkpoint inhibitors in mismatch repair-deficient endometrial cancer
    (RT061.21) IF : 10,3
    Grau Bejar JF, Yaniz Galende E, Zeng Q, Genestie C, Rouleau E, de Bruyn M, Klein C, Le Formal A, Edmond E, Moreau M, Plat A, Gouy S, Maulard A, Pautier P, Michels J, Oaknin A, Colomba-Blameble E, Leary A.J Immunother Cancer. 2024 Jul 1;12(7):e009143. doi: 10.1136/jitc-2024-009143.PMID: 38955419
  • Spatial Profiling of Ovarian Carcinoma and Tumor Microenvironment Evolution under Neoadjuvant Chemotherapy
    (RT128.14) IF : 10
    Yaniz-Galende E, Zeng Q, Bejar-Grau JF, Klein C, Blanc-Durand F, Le Formal A, Pujade-Lauraine E, Chardin L, Edmond E, Marty V, Ray-Coquard I, Joly F, Ferron G, Pautier P, Berton-Rigaud D, Lortholary A, Dohollou N, Desauw C, Fabbro M, Malaurie E, Bonichon-Lamaichhane N, Bello Roufai D, Gantzer J, Rouleau E, Genestie C, Leary A.Clin Cancer Res. 2024 Jul 1;30(13):2790-2800. doi: 10.1158/1078-0432.CCR-23-3836.PMID: 38669064
  • DiPRO1 distinctly reprograms muscle and mesenchymal cancer cells.
    (PE) IF : 9
    Rich J, Bennaroch M, Notel L, Patalakh P, Alberola J, Issa F, Opolon P, Bawa O, Rondof W, Marchais A, Dessen P, Meurice G, Le-Gall M, Polrot M, Ser-Le Roux K, Mamchaoui K, Droin N, Raslova H, Maire P, Geoerger B, Pirozhkova I.
    EMBO Mol Med. 2024 Aug;16(8):1840-1885. doi: 10.1038/s44321-024-00097-z. Epub 2024 Jul 15. PMID: 39009887
  • Development of Novel Models of Aggressive Variants of Castration-resistant Prostate Cancer.
    (PE + PETRA 2021-04) IF : 8,2
    Bigot L, Sabio J, Poiraudeau L, Annereau M, Menssouri N, Helissey C, Déas O, Aglave M, Ibrahim T, Pobel C, Nobre C, Nicotra C, Ngo-Camus M, Lacroix L, Rouleau E, Tselikas L, Judde JG, Chauchereau A, Bernard-Tessier A, Patrikidou A, Naoun N, Flippot R, Colomba E, Fuerea A, Albiges L, Lavaud P, Massard C, Friboulet L, Fizazi K, Besse B, Scoazec JY, Loriot Y.
    Eur Urol Oncol. 2024 Jun;7(3):527-536. doi: 10.1016/j.euo.2023.10.011. Epub 2023 Oct 27. PMID: 38433714
  • The Benefit of Combining Docetaxel with Androgen Deprivation Therapy in Localized and Metastatic Hormone-sensitive Prostate Cancer is Predicted by ERG Expression: An Analysis of Two GETUG Phase 3 Trials.
    (RT016.07 + RT125.13) IF : 8,2
    Rajpar S, Ibrahim T, Carmel A, Merabet Z, Vielh P, Foulon S, Lesaunier F, Delva R, Rolland F, Priou F, Ferrero JM, Houédé N, Mourey L, Théodore C, Krakowski I, Faivre L, Habibian M, Culine S, Gravis G, Chauchereau A, Fizazi K.
    Eur Urol Oncol. 2024 Jul 20:S2588-9311(24)00173-1. doi: 10.1016/j.euo.2024.06.015. Online ahead of print. PMID: 39034169
  • Bias reduction using combined stain normalization and augmentation for AI-based classification of histological images.
    (transmission protocole H&E) IF : 7
    Franchet C, Schwob R, Bataillon G, Syrykh C, Péricart S, Frenois FX, Penault-Llorca F, Lacroix-Triki M, Arnould L, Lemonnier J, Alliot JM, Filleron T, Brousset P.
    Comput Biol Med. 2024 Mar;171:108130. doi: 10.1016/j.compbiomed.2024.108130. Epub 2024 Feb 8. PMID: 38387381
  • Nonpersistent Nanoarchitectures Enhance Concurrent Chemoradiotherapy in an Immunocompetent Orthotopic Model of HPV+ Head/Neck Carcinoma
    (PE) IF : 6,4
    Gonnelli A, Gerbé de Thoré M, Ermini ML, Frusca V, Zamborlin A, Signolle N, Bawa O, Clémenson C, Meziani L, Bergeron P, El-Azrak I, Sarogni P, Mugnaioli E, Giannini N, Drava G, Deutsch E, Paiar F, Mondini M, Voliani V
    Adv Mater. 2024 Jul;36(28):e2400949. doi: 10.1002/adma.202400949. Epub 2024 May 27. PMID: 38761135
  • Association of the Genomic Profile of Medullary Thyroid Carcinoma with Tumor Characteristics and Clinical Outcomes in an International Multicenter Study.
    (RT032.13)  IF : 5,8
    Xu B, Viswanathan K, Ahadi MS, Ahmadi S, Alzumaili B, Bani MA, Baudin E, Behrman DB, Capelletti M, Chau NG, Chiarucci F, Chou A, Clifton-Bligh R, Coluccelli S, de Biase D, De Leo A, Dogan S, Fagin JA, Fuchs TL, Glover AR, Hadoux J, Lacroix L, Lamartina L, Lubin DJ, Luxford C, Magliocca K, Maloberti T, Mohanty AS, Najdawi F, Nigam A, Papachristos AJ, Repaci A, Robinson B, Scoazec JY, Shi Q, Sidhu S, Solaroli E, Sywak M, Tuttle RM, Untch B, Barletta JA, Al Ghuzlan A, Gill AJ, Ghossein R, Tallini G, Ganly I.
    Thyroid. 2024 Feb;34(2):167-176. doi: 10.1089/thy.2023.0279. Epub 2023 Nov 7. PMID: 37842841
  • Divergent HLA variations and heterogeneous expression but recurrent HLA loss-of- heterozygosity and common HLA-B and TAP transcriptional silencing across advanced pediatric solid cancers
    (RT118.22) IF : 5,7
    Lim WC, Marques Da Costa ME, Godefroy K, Jacquet E, Gragert L, Rondof W, Marchais A, Nhiri N, Dalfovo D, Viard M, Labaied N, Khan AM, Dessen P, Romanel A, Pasqualini C, Schleiermacher G, Carrington M, Zitvogel L, Scoazec JY, Geoerger B, Salmon J.
    Front Immunol. 2024 Jan 22;14:1265469. doi: 10.3389/fimmu.2023.1265469. eCollection 2023.
    PMID: 38318504
  • Antitumoral effect of local injection of TLR-9 agonist emulsified in Lipiodol with systemic anti-PD-1 in a murine model of colorectal carcinoma.
    (PE) IF : 5,7
    Grindel AL, Fretellier N, Soares M, Bouzakher N, Millot Maysounabe V, Santus R, Bawa O, Wintrebert M, Couquelet C, Robert P, Emile JF, Capron C.
    Front Immunol. 2024 Jan 16;14:1272246. doi: 10.3389/fimmu.2023.1272246. eCollection 2023. PMID: 38292484
  • Molecular profiling of biliary tract cancers reveals distinct genomic landscapes between circulating and tissue tumor DNA
    (RT146.18) IF : 2,5
    Astier C, Ngo C, Colmet-Daage L, Marty V, Bawa O, Nicotra C, Ngo-Camus M, Italiano A, Massard C, Scoazec JY, Smolenschi C, Ducreux M, Hollebecque A, Postel-Vinay S.Exp Hematol Oncol. 2024 Jan 8;13(1):2. doi: 10.1186/s40164-023-00470-7.PMID: 38191492
  • Biomarker Identification in Liver Cancers Using Desorption Electrospray Ionization Mass Spectrometry (DESI-MS) Imaging: An Approach for Spatially Resolved Metabolomics.
    (PE) IF : 0,42
    Chen H, Durand S, Bawa O, Bourgin M, Montégut L, Lambertucci F, Motiño O, Li S, Nogueira-Recalde U, Anagnostopoulos G, Maiuri MC, Kroemer G, Martins I.
    Methods Mol Biol. 2024;2769:199-209. doi: 10.1007/978-1-0716-3694-7_15. PMID: 38315399
Catégorie de la page: